Explain this page
Arphra AIPlain-English read on Bank of America Corporation’s valuationEDGAR · most recent
No SEC filings on file for this issuer.
Arphra is for informational purposes only and is not financial, investment, tax, or legal advice. Quotes are delayed where applicable. Past performance does not predict future results. Backtests, scenario stress tests, and AI-generated commentary use stylized assumptions and may differ substantially from realized outcomes. The fair-value estimates and committee verdicts shown here are model outputs, not recommendations to transact. Verify against primary sources before relying on any number.
AI · Disclosure analysis
Arphra AIClick Analyze filings to have Arphra AI review the last 80 SEC filings for BAC and return: a one-paragraph summary of recent disclosure activity, 3-5 thematic patterns, 3-5 notable individual filings worth flagging, and 2-3 watch items.
M&A activity
3DBWhole-company transactions where BAC is acquirer or target.
| Date | Role | Counterparty | Filing |
|---|---|---|---|
| Mar 15, 2022 | Target | Biotech Acquisition Company | SEC → |
| Aug 02, 2005 | Target | BANK OF AMERICA CORP /DE/ | SEC → |
| Dec 04, 2003 | Target | BANK OF AMERICA CORP /DE/ | SEC → |
Form-type mix
- No data.
| Filed | Accepted | Form | Description | Link |
|---|---|---|---|---|
| No filings in this group. | ||||